NIH Awards Fletcher R21 Grant to Advance Novel Treatment Strategy for Aggressive Leukemias
November 20, 2026
Two-year, $427,625 award supports innovative approach designed to overcome treatment resistance in leukemia
November 20, 2026
Two-year, $427,625 award supports innovative approach designed to overcome treatment resistance in leukemia